Filed in archive
Developments
, News
, Treatment
by Gloria Gamat on October 26, 2007
Approved by the FDA in October 2006, the diabetes drug by Merck - Januvia (sitagliptin) - is a prescription medicine being used as part of a treatment programme (including diet and exercise) to lower blood sugar in patients with type 2 diabetes.
Januvia is administered either alone or as an adjunctive therapy with certain other drugs, such as metformin and thiazolidinediones.
Now, the FDA has approved new uses for Januvia:
The above follow-up application of Januvia was supported by three studies on the safety and efficacy of Januvia.
Find more details from Medical News Today.
Januvia is administered either alone or as an adjunctive therapy with certain other drugs, such as metformin and thiazolidinediones.
Januvia is a DPP-4 inhibitor: it inhibits glucagon production (the enzyme that increases blood sugar), and stimulates insulin (the enzyme that decreases blood sugar).
Now, the FDA has approved new uses for Januvia:
- could also be used in combination with sulfonylurea and metformin, in cases when the two are not enough to control blood sugar
- could be used with metformin as an initial therapy
The above follow-up application of Januvia was supported by three studies on the safety and efficacy of Januvia.
Find more details from Medical News Today.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/98905
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Diabetes Drug Januvia Has New FDA-Approved Uses:
|
Rating: 7.50 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
